Access to skin prick testing reagents

Skin prick testing is the primary mode of testing for immediate IgE-mediated allergy for clinical immunology/allergy specialists and other doctors or nurse practitioners who have been trained to manage patients with allergic disease. Skin prick testing provides high quality information when performed and interpreted correctly.

This webpage contains information about recent changes to the Therapeutic Goods Administration (TGA) Authorised Prescriber scheme, as well as a list of Suppliers and Further Information.

Important change to TGA Authorised Prescriber scheme

The Therapeutic Goods Administration (TGA) has streamlined the Authorised Prescriber application process to access allergens for skin prick and intradermal testing, by removing the requirement for Human Research Ethics Committee (HREC) approval or specialist college endorsement. 

This change to the TGA Authorised Prescriber scheme will simplify access to skin testing reagents for ASCIA members, which was raised as one of ten main issues in the ASCIA Submisison to the Parliamentary Inquiry on Allergies and Anaphylaxis. Access to skin testing reagents has been a major issue for ASCIA members since 2008, so this change is welcome news. 

The changes to the TGA Authorised Prescriber scheme (effective October 2020) will streamline the application process for medicines considered to have an established history of use in Australia.  The TGA list of ‘medicines’ with an established history of use includes:

  • Allergens for skin prick testing (SPT), including control solutions, for confirmation of suspected allergic reactions – TGA code AP3.
  • Allergens for intradermal testing (IDT), including control solutions, for confirmation of suspected allergic reactions – TGA code AP2.

The changes include removal of the requirement for HREC approval or specialist college endorsement to be submitted to the TGA in circumstances where a medical practitioner is applying to become an Authorised Prescriber of medicines with an established history of use, as specified in subregulation 12B(1B) of the Therapeutic Goods Regulations 1990

A printable (pdf) version of the list is on the TGA website list of medicines with an established history of use and is also available here  pdfTGA-list-of-medicines-with-an-established-history-of-use-2020-October112.58 KB

The application process has now been updated for use under the new arrangements when renewal applications are due. The updated applcation form is available on the TGA website www.tga.gov.au/form/authorised-prescribers#apf and is also available here docxTGA-authorised-prescriber-scheme-application-form-201008144.64 KB

HREC or institutional approval may still be required to use certain ‘unapproved’ therapeutic goods within an institution, such as a hospital, and for products that are not included in subregulation 12B(1B) of the Therapeutic Goods Regulations 1990. Further details on applying for approval/endorsement are available in our guidance document Authorised Prescriber Scheme - Guidance for Medical Practitioners, Human Research Ethics Committees, Specialist Colleges and Sponsors.

For further information email This email address is being protected from spambots. You need JavaScript enabled to view it. 

There have been supply issues for skin testing allergens since 2008, due to the discontinuation of Hollister-Steir allergens, which were registered with the TGA. Since 2008 it has been necessary for medical practitioners in Australia to use allergens for skin testing that are not registered with the TGA, requiring endorsement as a TGA Authorised Prescriber (see above) or a Special Access Scheme (SAS) C application, as detailed below.

TGA Special Access Scheme (SAS) Category C is a notification pathway which allows health practitioners to supply goods that are deemed to have an established history of use without first seeking prior approval. The goods deemed to have an established history of use are specified in a list along with their indications and the type of health practitioner authorised to supply these products for the respective indications. 

For details about SAS go to www.tga.gov.au/form/special-access-scheme 
 
To use the online the SAS online system go to https://www.tga.gov.au/special-access-scheme-online-system

Suppliers 

Stallergenes Greer
Suppliers of Stallergenes Greer, Hollister Stier, Albey and Hymenoptera products
PO Box 281 Mona Vale - NSW Australia
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: 1800 824 166 (AU)
AMSL Allergy

Suppliers of Inmunotek immunotherapy and SPT, ALK-Abello SPT, Lincoln lancet systems, and SmartPractice patch test products

2 McCabe Place Chatswood - NSW Australia
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: 02 9882 3666 (AU) 
NZMS
Suppliers of Inmunotek immunotherapy and SPT (New Zealand)
2a Fisher Crescent Mt Wellington - Auckland New Zealand
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: 09 259 4062
Gamma Allergy  
Suppliers of Gamma Allergy products
Suite 15, 3108 Surfers Paradise Blvd Surfers Paradise - QLD Australia
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. 
Phone: 1300 881 405 (AU) 
Ferrer Pharma Pty Ltd 
Suppliers of Lofarma, Diater (including antibiotic and venom allergens), Chemotechnique patch test products, Yilmaz Plastic SPT Lancets and ALEX2 Allergy IVD Tests
4 Isabel Close, Cherrybrook - NSW Australia
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: 1300 022 789 (AU)
Sanatio Allergy Pty Ltd
Suppliers of allergy diagnostics products (skin prick and the AllerDetect Dry Blood Spot Test), immunotherapy treatment sets and allergy avoidance bedding
L1042 866 Bourke St,Waterloo - NSW Australia
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: 1300 095419 (AU)

Further information

Health Professionals:
ASCIA Skin Prick Testing Guide for the Diagnosis of Allergic Disease 
 
Patients, Consumers and Carers:
ASCIA Allergy Testing information

Content updated October 2020

Mod ASCIA Member
Donate to AIFA
go to NAS website
Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.